Biomarin Pharmaceutical reported $0.18 in EPS Earnings Per Share for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Eps Change
Acadia Pharmaceuticals ACAD:US $ 0K 0K
Acorda Therapeutics ACOR:US $ -1.93 1.26
Agios Pharmaceuticals AGIO:US -1.74 0
Alnylam Pharmaceuticals ALNY:US $ -2 0.16
Amgen AMGN:US $ 4.25 0.11
Bayer BAYN:GR € 3.53 2.27
Biogen BIIB:US $ 4.38 0.99
Biomarin Pharmaceutical BMRN:US $ 0.18 0.5
Bluebird Bio BLUE:US $ -1.66 0.48
Gilead Sciences GILD:US $ 2.12 1.43
Insmed INSM:US -0.8 0.15
Intercept Pharmaceuticals ICPT:US $ -0.58 0.65
IONIS PHARMACEUT IONS:US $ -0.46 1.87
Moderna Inc MRNA:US 8.58 2.71
Neurocrine Biosciences NBIX:US $ 0.3 0.38
Ptc Therapeutics PTCT:US $ -1.78 0.25
Puma Biotechnology PBYI:US $ -0.08 0.18
Regeneron Pharmaceuticals REGN:US $ 11.49 9.83
Sangamo Biosciences SGMO:US $ -0.3 0.04
Sanofi SNY:US $ 1.02 0.23
Sarepta Therapeutics SRPT:US -1.2 0.22
Seattle Genetics SGEN:US $ -0.74 0.21
Ultragenyx Pharmaceutical RARE:US $ -2.19 0.4
United Therapeutics UTHR:US $ 5.03 2.68
Vertex Pharmaceuticals VRTX:US $ 3.52 0.15
YTE INCY:US $ 0.55 0.45